semaglutide gastric stasis class action in louisiana glp-1 lawsuit attorney GLP-1 Gastroparesis Lawsuit: Stomach Paralysis and Delayed Gastric Emptying GI Injury Cases Louisiana spent over $1B on – semaglutide gastric stasis class action

Weight loss on peptide therapy is not linear, and temporary stalls of 1-3 weeks are normal even on optimal protocols

When you stop taking Ozempic, youll stop experiencing the therapeutic benefits of the medication, including improved blood sugar control and reduced cardiovascular risk

Using a hydrating, barrier-supportive skincare routine during this adjustment period can speed resolution

When you come in, the first thing your provider should do is listen

What started as a market barely worth $1 billion in 2020 is now on track to hit a staggering $100 billion by 2030

The weight loss was accompanied by improvements in glycemic control, with significant reductions in HbA1c levels, suggesting potential benefits for patients with both obesity and diabetes